ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,869,000 | +6.0% | 40,606 | 0.0% | 0.15% | -10.9% |
| Q1 2020 | $3,649,000 | -20.3% | 40,606 | -53.0% | 0.16% | -4.6% |
| Q4 2019 | $4,576,000 | +34.2% | 86,313 | 0.0% | 0.17% | +16.1% |
| Q3 2019 | $3,410,000 | -55.9% | 86,313 | -54.2% | 0.15% | -52.8% |
| Q2 2019 | $7,739,000 | -11.8% | 188,388 | 0.0% | 0.32% | -11.2% |
| Q1 2019 | $8,773,000 | +18.0% | 188,388 | +10.3% | 0.36% | +11.9% |
| Q4 2018 | $7,437,000 | -23.9% | 170,766 | 0.0% | 0.32% | -10.2% |
| Q3 2018 | $9,773,000 | +17.9% | 170,766 | 0.0% | 0.35% | +12.7% |
| Q2 2018 | $8,286,000 | -22.4% | 170,766 | -37.5% | 0.31% | -24.3% |
| Q1 2018 | $10,678,000 | -11.2% | 273,098 | -3.6% | 0.42% | -10.6% |
| Q4 2017 | $12,027,000 | +440.3% | 283,383 | +375.0% | 0.46% | +480.0% |
| Q3 2017 | $2,226,000 | +22.8% | 59,654 | 0.0% | 0.08% | +19.4% |
| Q2 2017 | $1,813,000 | +25.8% | 59,654 | +9.6% | 0.07% | +19.6% |
| Q1 2017 | $1,441,000 | +3.7% | 54,450 | 0.0% | 0.06% | -5.1% |
| Q4 2016 | $1,390,000 | – | 54,450 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |